University of Colorado Anschutz

Healing, discovery and hope happen when we dream and work in concert with each other. From restoring sound and sight to advancing brain health, #CUAnschutz is leading research that brings new hope to patients everywhere. ✨ Never dream alone. cuanschutz.edu/dreams

🏆 @usnews recognizes the continued impact of #CUAnschutz across disciplines, with multiple programs once again ranked among the nation's best. 🗞️ See where our programs landed: bit.ly/4efOvRH

#EsophagealCancerAwarenessMonth: Researchers have developed a new AI tool with a 90% accuracy rate to predict Barrett’s Esophagus recurrence after therapy: bit.ly/4c8wzG4

Neurosurgery experts at #CUAnschutz performed Colorado’s first brain-computer interface surgery at @uchealth University of Colorado Hospital, marking a significant advance for those with neurological injury or disease. 🧠 🗞️ Read more: bit.ly/4mjX93H

#CUAnschutz doctors, led by Jessica Rove, MD, recently completed the region's first robotic aortic valve replacement. 🫀 This minimally invasive approach helps patients return to normal activity faster. 🗞️ Read more: bit.ly/4vbWFAT

Ludeman Center researcher and professor of geriatric medicine at @CUAnschutz Kerrie Moreau, PhD, is featured in an in-depth Q&A for CU Anschutz to discuss the differences in cardiovascular disease between sexes. Read the article now. news.cuanschutz.edu/news-stories/w…

New #CUAnschutz research explores blood flow restriction, a technique using a pressure cuff to limit blood flow during exercise, for strength training in #Parkinsons patients. Findings show it’s feasible and may expand exercise access for people with PD. bit.ly/4se7EHj

Osteoarthritis is the 3rd most common disease in the U.S. With funding from @ARPA_H, researchers at CU Boulder, @CUAnschutz and @ColoradoStateU developed therapies that help damaged joints repair themselves within weeks (animal studies). More @nytimes ↓ nyti.ms/4c7hgxl

🎙️ On this episode of #OncLiveOnAir, John Marshall, MD, of @LombardiCancer and Christopher Lieu, MD, of @CUAnschutz discussed the clinical relevance of KRAS G12C and pan-RAS inhibitors in the management of pancreatic and colorectal cancers. Listen to the whole episode here ➡️: hubs.li/Q049FD4x0 #pancsm #crcsm #oncology

🗞️ Gates Institute at #CUAnschutz has received FDA clearance to advance its CAR T-cell therapy into a Phase 1 clinical trial—the first CAR T-cell therapy developed entirely on our campus to be authorized for clinical testing. Learn more. ⬇️ bit.ly/4vfAPfR

Accomplished cellist Jurgen de Lemos performed in the lobby of our clinic @uchealth to thank Christopher Roark, MD and the rest of his care team for saving his life. Thank you for the incredible performance! #Neurosurgery #UCHealth #CUAnschutz #CUAnschutzSOM #Cello

Congratulations to #Hospitalist @vineet_chopra, MBBS, MD, MSc, on being named a Master in Hospital Medicine at #SHMConverge26! This well-deserved recognition highlights his leadership and contributions to the field. We’re proud to have Dr. Chopra at @CUAnschutz.

#Breastcancer is more difficult to treat once it spreads to other parts of the body - including the lungs. 🫁 New #CUAnschutz research shows how breast cancer cells can trigger the lung’s natural healing response, creating conditions that help tumors grow. bit.ly/4t0wb3T

Becky Grubb credits the CU Anschutz Cancer Center’s multidisciplinary care and clinical trials – plus a ‘huge village’ of support – for her quality of life after a stage IV colorectal cancer diagnosis: bit.ly/3PHzjTp

Researchers have long associated PFAS, or “forever chemicals,” to certain severe birth defects. New #CUAnschutz research sheds light on exactly how these pollutants harm a fetus, and why one PFAS in particular can disrupt a baby’s facial development. 💡 ⬇️ bit.ly/4bIZq4Q

Today is #NationalDoctorsDay, and we are proud to have exceptional physicians on our campus who turn dreams into new discoveries, new therapies and new solutions for those we serve—helping to make #CUAnschutz the place where dreams live. ✨

Check out my new issue of Science Matters, highlighting how our researchers are advancing discoveries in #Parkinsons, #DownSyndrome and more. Plus, learn about the scientists & staff recognized at the @CUAnschutz Research Awards ceremony. linkedin.com/pulse/science-… via @LinkedIn

For those living with #HIV, taking a daily pill can be a challenge. A new clinical trial at #CUAnschutz shows that a monthly injectable option can significantly reduce the risk of treatment failure for those who need a different approach. 💊 bit.ly/4lIe7s8

During an unseasonably warm spring, #CUAnschutz expert Jay Lemery, MD, defines what a "heat dome" is and how rising temperatures can increase the risk of certain health complications. Read the Q&A below. ⬇️ ☀️ bit.ly/47qCy7G

We're still feeling all of the excitement of #MatchDay! Congratulations @CUMedicalSchool Class of 2026—this is just the beginning! 💛🖤

🎙️ On this episode of OncLive On Air, hear @marshalj23 and Christopher Lieu, MD, discuss the clinical relevance of biomarkers in the management of GI cancers. @LombardiCancer @CUAnschutz @CUCancerCenter #oncology Listen on our site or wherever you get your podcasts➡️ onclive.com/view/new-trial…